AGF MANAGEMENT LTD

Position in GILD — Gilead Sciences, Inc.

CIK 1003518 TORONTO, A6

Position in GILD

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$5,500,590

-$1,747,764 QoQ

Shares Held

43,538

-16.3% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#561

of 2,266 holders

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

AGF MANAGEMENT LTD holds $1,321,975,737 across 10 Drug Manufacturers - General names. GILD ranks #7 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	556,470	$667,446,866
2	JNJ	Johnson & Johnson	1,545,100	$392,409,044
3	ABBV	AbbVie Inc.	652,937	$164,305,065
4	NVS	Novartis AG	360,354	$56,474,678
5	BMY	Bristol Myers Squibb Co	334,104	$19,251,072
6	PFE	Pfizer Inc	434,814	$10,470,321
7	GILD	Gilead Sciences, Inc. This page	43,538	$5,500,590
8	AMGN	Amgen Inc	9,492	$3,437,243

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,500,590	43,538	-16.3%	Shares	Sole	2026-08-10
2026-03-31	$7,248,354	52,008	+99.6%	Shares	Sole	2026-05-07
2025-12-31	$3,198,849	26,062	+13.8%	Shares	Sole	2026-02-17
2025-09-30	$2,542,233	22,903	+81.8%	Shares	Sole	2025-11-04
2025-06-30	$1,396,962	12,600	-69.2%	Shares	Sole	2025-08-06
2024-09-30	$3,425,366	40,856	+10.3%	Shares	Sole	2024-11-12
2024-06-30	$2,540,284	37,025	-20.4%	Shares	Sole	2024-08-07
2024-03-31	$3,405,172	46,487	-0.4%	Shares	Sole	2024-05-13
2023-12-31	$3,782,518	46,692	-4.7%	Shares	Sole	2024-02-06
2023-09-30	$3,673,482	49,019	-8.1%	Shares	Sole	2023-11-13
2023-06-30	$4,111,067	53,342	+9.8%	Shares	Sole	2023-08-09
2023-03-31	$4,031,760	48,593	-55.9%	Shares	Sole	2023-05-02
2022-12-31	$9,458,179	110,171	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.